ATOS - ATOSSA THERAPEUTICS, INC.

QQQ $ 473.19 $ -0.24 (-0.05 %)

DIA $ 411.97 $ 2.70 (0.66 %)

SPY $ 560.27 $ 0.00 (0 %)

TLT $ 100.12 $ -0.47 (-0.47 %)

GLD $ 237.77 $ 0.18 (0.08 %)

Previous Close

$ 1.5

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.62 - $ 2.31

Volume

508,649

Average Volume

Market Cap

188.64M

Beta (5Y Monthly)

$ 1.67

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2024	06-30-2024	10-Q
2	05-13-2024	03-31-2024	10-Q
3	04-01-2024	12-31-2023	10-K
4	11-13-2023	09-30-2023	10-Q
5	08-14-2023	06-30-2023	10-Q
6	05-15-2023	03-31-2023	10-Q
7	03-22-2023	12-31-2022	10-K
8	11-07-2022	09-30-2022	10-Q
9	08-08-2022	06-30-2022	10-Q
10	05-09-2022	03-31-2022	10-Q
11	02-28-2022	12-31-2021	10-K
12	11-15-2021	09-30-2021	10-Q
13	08-13-2021	06-30-2021	10-Q
14	05-14-2021	03-31-2021	10-Q
15	03-31-2021	12-31-2020	10-K
16	11-13-2020	09-30-2020	10-Q
17	08-13-2020	06-30-2020	10-Q
18	05-13-2020	03-31-2020	10-Q
19	03-26-2020	12-31-2019	10-K
20	11-13-2019	09-30-2019	10-Q
21	08-13-2019	06-30-2019	10-Q
22	05-13-2019	03-31-2019	10-Q
23	03-28-2019	12-31-2018	10-K
24	11-14-2018	09-30-2018	10-Q
25	08-13-2018	06-30-2018	10-Q
26	05-14-2018	03-31-2018	10-Q
27	03-08-2018	12-31-2017	10-K
28	11-13-2017	09-30-2017	10-Q
29	08-14-2017	06-30-2017	10-Q
30	05-11-2017	03-31-2017	10-Q
31	03-16-2017	12-31-2016	10-K
32	11-14-2016	09-30-2016	10-Q
33	08-12-2016	06-30-2016	10-Q
34	05-05-2016	03-31-2016	10-Q
35	03-30-2016	12-31-2015	10-K
36	11-12-2015	09-30-2015	10-Q
37	08-06-2015	06-30-2015	10-Q
38	05-13-2015	03-31-2015	10-Q
39	03-30-2015	12-31-2014	10-K
40	11-12-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

dominos-pizza-to-510-here-are-10-top-analyst-forecasts-for-wednesday

Domino's Pizza To $510? Here Are 10 Top An...
09/11/2024 13:08:03

Ascendiant Capital Maintains Buy on Atossa...
09/11/2024 09:46:11

Ascendiant Capital analyst Edward Woo maintains Atossa Therapeutics (NASDAQ:ATOS) with a Buy and raises the price target fro...

Atossa Therapeutics Announces Support Of F...
09/10/2024 12:31:17

Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), today announced its support of the U.S. Fo...

Atossa Therapeutics Granted New Patent Dir...
08/28/2024 12:33:34

Atossa Therapeutics And Quantum Leap Healt...
08/21/2024 12:30:51

HC Wainwright & Co. Reiterates Buy on Atos...
08/12/2024 17:53:30

HC Wainwright & Co. analyst Emily Bodnar reiterates Atossa Therapeutics (NASDAQ:ATOS) with a Buy and maintains $6 price ...

Atossa Therapeutics Q2 EPS $(0.05) Beats $...
08/12/2024 12:36:53

Atossa Therapeutics (NASDAQ:ATOS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $...

Atossa Therapeutics Completes Enrollment O...
07/22/2024 12:33:45

Atossa Therapeutics Appoints Heather Rees ...
07/02/2024 20:16:04

Rees most recently served as Atossa's Senior Vice President of Finance and Principal Accounting Officer.

HC Wainwright & Co. Reiterates Buy on Atos...
06/28/2024 15:12:47

HC Wainwright & Co. analyst Emily Bodnar reiterates Atossa Therapeutics (NASDAQ:ATOS) with a Buy and maintains $6 price ...

Atossa Therapeutics Announces Updated Prot...
06/28/2024 12:36:28

Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company") today announced protocol changes in the pre...

Cantor Fitzgerald Reiterates Overweight on...
06/20/2024 17:26:50

Cantor Fitzgerald analyst Louise Chen reiterates Atossa Therapeutics (NASDAQ:ATOS) with a Overweight.

Atossa To Join Russell 3000 Index
06/17/2024 12:34:29

Ascendiant Capital Maintains Buy on Atossa...
06/06/2024 17:07:25

Ascendiant Capital analyst Edward Woo maintains Atossa Therapeutics (NASDAQ:ATOS) with a Buy and raises the price target fro...

Atossa Therapeutics Last Patient Its Phase...
05/15/2024 12:39:30

Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company") today announced that the last patient in th...

Cantor Fitzgerald Reiterates Overweight on...
05/14/2024 13:25:09

Cantor Fitzgerald analyst Louise Chen reiterates Atossa Therapeutics (NASDAQ:ATOS) with a Overweight.

HC Wainwright & Co. Maintains Buy on Atoss...
05/13/2024 16:54:59

HC Wainwright & Co. analyst Emily Bodnar maintains Atossa Therapeutics (NASDAQ:ATOS) with a Buy and raises the price tar...

Atossa Therapeutics Q1 2024 Adj EPS $(0.05...
05/13/2024 12:54:22

Atossa Therapeutics (NASDAQ:ATOS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $...

Atossa Therapeutics Announces Support Of N...
05/07/2024 12:46:50

Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company") today announced its support of new guidelin...

Atossa Therapeutics Announces Expanded Res...
04/29/2024 12:34:28

Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company") today announced an expanded research agreem...